Sapropterin dihydrochloride for phenylketonuria
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effectiveness and safety of sapropterin dihydrochloride in decreasing blood Phe levels in people with PKU.